Consolidated Statements of Changes in Mezzanine Equity and Shareholders' Equity - USD ($)	Redeemable Noncontrolling Interest [Member]	Mezzanine Equity [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscription Receivable [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance at Dec. 31, 2022	$ 885,028	$ 885,028	$ 1,386	$ 94,415,058		$ (79,207,786)	$ (536,734)	$ 14,671,924
Beginning balance, shares at Dec. 31, 2022			138,554
Mezzanine equity balance, shares at Dec. 31, 2022	1,000
Stock-based compensation				2,150,160				2,150,160
Issuance of common shares for vested RSU			$ 69	(69)
Issuance of common shares for vested RSU, shares			6,910
Issuance of Inducement Warrants, net of offering costs of $239,302				1,967,424	(280,500)			1,686,924
Exercise of warrants and preferred investment options			$ 279	1,536,861	(1,537,140)
Exercise of warrants and preferred investment options, shares			27,867
Foreign exchange translation loss							(33,015)	(33,015)
Net loss						(17,291,732)		(17,291,732)
Preferred dividends attributable to redeemable non-controlling interest	19,041	19,041		(19,041)				(19,041)
Accretion of embedded derivative to redemption value	147,988	147,988		(147,988)				(147,988)
Redemption of Series A preferred stock	$ (1,052,057)	(1,052,057)
Redemption of Series A preferred stock, shares	(1,000)
Issuance of common shares for deferred offering costs			$ 93	255,014				255,107
Issuance of common shares for deferred offering costs, shares			9,294
Induced conversion of warrants and preferred investment options				683,997				683,997
Balance at Dec. 31, 2023			$ 1,827	100,841,416	(1,817,640)	(96,499,518)	(569,749)	1,956,336
Ending balance, shares at Dec. 31, 2023			182,625
Mezzanine equity balance, shares at Dec. 31, 2023
Common stock sold under the Equity Distribution Agreement, net of offering costs of $583,713			$ 1,112	1,807,677				1,808,789
Common stock sold under the Equity Distribution Agreement, net of offering cost, shares			111,200
Issuance of direct offering shares (see Note 8)			$ 458	770,835				771,293
Issuance of direct offering shares, shares			45,780
Exercise of Inducement Warrants for common stock			$ 1,303	2,675,677				2,676,980
Exercise of Inducement Warrants for common stock, shares			130,267
Stock-based compensation				1,562,392				1,562,392
Issuance of common shares for vested RSU			$ 18	(18)
Issuance of common shares for vested RSU, shares			1,830
Issuance of Inducement Warrants, net of offering costs of $239,302				(12,821)	280,500			267,679
Exercise of warrants and preferred investment options			$ 469	(469)	1,537,140			1,537,140
Exercise of warrants and preferred investment options, shares			46,934
Common stock sold under the Purchase Agreement, net of offering costs of $471,756			$ 1,593	610,360				611,953
Common stock sold under the Purchase Agreement, net of offering costs, shares			159,366
Foreign exchange translation loss							(24,768)	(24,768)
Net loss						(9,574,987)		(9,574,987)
Preferred dividends attributable to redeemable non-controlling interest
Accretion of embedded derivative to redemption value
Balance at Dec. 31, 2024			$ 6,780	$ 108,255,049		$ (106,074,505)	$ (594,517)	$ 1,592,807
Ending balance, shares at Dec. 31, 2024			678,002